Pinkas Jan

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Crescent Biopharma, Inc. (CBIO)

Transaction date 16 Sep 2026

Planned sale

Price

129.29

Quantity 47,172 +33.1%

Value US$2,395,031

Comments Filing

Crescent Biopharma, Inc. (CBIO)

Transaction date 22 Jun 2026

Planned sale

Price

353.35

Quantity 20,671 +38.6%

Value US$1,943,668

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-09-18	2026-09-16	Crescent Biopharma, Inc. (CBIO)	PlS Planned sale	47,172 +33.1% 129.29 US$2,395,031	47,172 +33.1%	129.29	US$2,395,031
2026-06-23	2026-06-22	Crescent Biopharma, Inc. (CBIO)	PlS Planned sale	20,671 +38.6% 353.35 US$1,943,668	20,671 +38.6%	353.35	US$1,943,668